Qualcomm, Merck, Rockwell, Simon Property Group picked by CNBC analysts
CNBC analysts highlighted Qualcomm, Merck, Rockwell Automation, and Simon Property Group as final trades. Qualcomm set a $40 billion non-handset revenue target for fiscal 2029, while Merck reported positive Phase 3 data. Rockwell Automation authorized $1 billion in share buybacks, and Simon Property Group saw its price target raised by Barclays.

*this image is generated using AI for illustrative purposes only.
Market analysts on CNBC’s Halftime Report selected Qualcomm, Merck, Rockwell Automation, and Simon Property Group as their final trades, citing corporate developments and updated financial targets. Jim Lebenthal of Cerity Partners named Qualcomm, highlighting the company's accelerated diversification strategy announced at its 2026 Investor Day. The semiconductor company updated its long-term revenue targets, expecting non-handset revenue of $40 billion by fiscal 2029. This target includes more than $15 billion in data center revenue, more than $14 billion in IoT revenue, and $10 billion in Automotive revenue. Additionally, Qualcomm expanded its partnership with Hugging Face to advance open, developer-focused artificial intelligence across devices and cloud infrastructure.
Stephanie Link of Hightower Advisors chose Rockwell Automation following the company's announcement on June 9. Rockwell Automation’s board approved an additional $1 billion to repurchase shares of common stock and declared a quarterly dividend of $1.38 per share. Joseph M. Terranova of Virtus Investment Partners recommended Merck after the company announced on June 22 that its investigational therapy tulisokibart achieved the primary endpoint in a Phase 3 study for moderately to severely active ulcerative colitis. Merck described this as the first positive Phase 3 induction results for an anti-TL1A biologic.
Joshua Brown of Ritholtz Wealth Management picked Simon Property Group after Barclays analyst Richard Hightower maintained the stock with an Equal-Weight rating and raised the price target from $212 to $213.
Price Action
| Company | Ticker | Exchange | Price Change | Closing Price |
|---|---|---|---|---|
| Qualcomm | QCOM | NASDAQ | +3.8% | $204.90 |
| Rockwell Automation | ROK | NYSE | +4.1% | $479.39 |
| Merck | MRK | NYSE | +4% | $125.45 |
| Simon Property Group | SPG | NYSE | +1.5% | $225.49 |
How will Qualcomm's aggressive diversification into data centers and automotive impact its competitive positioning against established players like NVIDIA and Intel?
Can Rockwell Automation sustain its shareholder return strategy given potential cyclical downturns in the industrial automation sector?
What are the projected peak sales estimates for Merck's tulisokibart, and how might it reshape the treatment landscape for ulcerative colitis?

































